Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors

Bisphosphonic acids (or bisphosphonates) have been successfully used in the clinic treatment of bone diseases for over decades. Additionally, the antiinflammatory activity of these compounds has been gaining attention. In our previous work, we synthesized and in vivo evaluated the bisphosphonic este...

Full description

Bibliographic Details
Main Authors: Abimelek Cortes-Pacheco, María Adelina Jiménez-Arellanes, Francisco José Palacios-Can, José Antonio Valcarcel-Gamiño, Rodrigo Said Razo-Hernández, María del Carmen Juárez-Vázquez, Adolfo López-Torres, Oscar Abelardo Ramírez-Marroquín
Format: Article
Language:English
Published: Beilstein-Institut 2020-06-01
Series:Beilstein Journal of Organic Chemistry
Subjects:
Online Access:https://doi.org/10.3762/bjoc.16.108
_version_ 1818434934189064192
author Abimelek Cortes-Pacheco
María Adelina Jiménez-Arellanes
Francisco José Palacios-Can
José Antonio Valcarcel-Gamiño
Rodrigo Said Razo-Hernández
María del Carmen Juárez-Vázquez
Adolfo López-Torres
Oscar Abelardo Ramírez-Marroquín
author_facet Abimelek Cortes-Pacheco
María Adelina Jiménez-Arellanes
Francisco José Palacios-Can
José Antonio Valcarcel-Gamiño
Rodrigo Said Razo-Hernández
María del Carmen Juárez-Vázquez
Adolfo López-Torres
Oscar Abelardo Ramírez-Marroquín
author_sort Abimelek Cortes-Pacheco
collection DOAJ
description Bisphosphonic acids (or bisphosphonates) have been successfully used in the clinic treatment of bone diseases for over decades. Additionally, the antiinflammatory activity of these compounds has been gaining attention. In our previous work, we synthesized and in vivo evaluated the bisphosphonic esters 1 and 2, finding a moderate edema inhibition upon oral and topical administration on BALB/c mice. Thus, in this work, the bioisosteric replacement of an amide functional group for an ester afforded the new bisphosphonates 3–6, which had a moderate oral edema inhibition (25 mg/kg dose) and a significant topical antiinflammatory activity (2 mg/ear) on BALB/c mice, with 6 being the most active hit (55.9% edema inhibition), comparable to the positive control (55.5% edema inhibition) on a TPA topical model. Next, to assess the acute toxicity of the synthesized derivatives, test animals were administered with 50–100 mg/kg of 3–6, respectively, by an oral route, and after 14 days, neither lethality nor a significative weight loss were observed. Finally, a structure–activity relationship (SAR) and a molecular docking analysis of 3–6 helped us to explain the trend observed in biological tests. Considering all these aspects, we propose the inhibition of MMP-8 and MMP-9 as a possible action mechanism of the synthesized derivatives.
first_indexed 2024-12-14T16:44:52Z
format Article
id doaj.art-7f2c12e9a4154e5391106e51fb739bb1
institution Directory Open Access Journal
issn 1860-5397
language English
last_indexed 2024-12-14T16:44:52Z
publishDate 2020-06-01
publisher Beilstein-Institut
record_format Article
series Beilstein Journal of Organic Chemistry
spelling doaj.art-7f2c12e9a4154e5391106e51fb739bb12022-12-21T22:54:13ZengBeilstein-InstitutBeilstein Journal of Organic Chemistry1860-53972020-06-011611277128710.3762/bjoc.16.1081860-5397-16-108Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitorsAbimelek Cortes-Pacheco0María Adelina Jiménez-Arellanes1Francisco José Palacios-Can2José Antonio Valcarcel-Gamiño3Rodrigo Said Razo-Hernández4María del Carmen Juárez-Vázquez5Adolfo López-Torres6Oscar Abelardo Ramírez-Marroquín7Instituto de Química Aplicada, Universidad del Papaloapan. Tuxtepec, 68301, MexicoUnidad de Investigación Médica (UIM) en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI (CMN-SXXI), Instituto Mexicano del Seguro Social (IMSS). Av. Cuauhtémoc 330, Col. Doctores 06720, Ciudad de México (CdMx), MexicoCentro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos Avenida Universidad 1001, Chamilpa, 62210 Cuernavaca, Morelos, MexicoCentro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos Avenida Universidad 1001, Chamilpa, 62210 Cuernavaca, Morelos, MexicoCentro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos Avenida Universidad 1001, Chamilpa, 62210 Cuernavaca, Morelos, MexicoUnidad de Investigación Médica (UIM) en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI (CMN-SXXI), Instituto Mexicano del Seguro Social (IMSS). Av. Cuauhtémoc 330, Col. Doctores 06720, Ciudad de México (CdMx), MexicoInstituto de Química Aplicada, Universidad del Papaloapan. Tuxtepec, 68301, MexicoInstituto de Química Aplicada, Universidad del Papaloapan. Tuxtepec, 68301, MexicoBisphosphonic acids (or bisphosphonates) have been successfully used in the clinic treatment of bone diseases for over decades. Additionally, the antiinflammatory activity of these compounds has been gaining attention. In our previous work, we synthesized and in vivo evaluated the bisphosphonic esters 1 and 2, finding a moderate edema inhibition upon oral and topical administration on BALB/c mice. Thus, in this work, the bioisosteric replacement of an amide functional group for an ester afforded the new bisphosphonates 3–6, which had a moderate oral edema inhibition (25 mg/kg dose) and a significant topical antiinflammatory activity (2 mg/ear) on BALB/c mice, with 6 being the most active hit (55.9% edema inhibition), comparable to the positive control (55.5% edema inhibition) on a TPA topical model. Next, to assess the acute toxicity of the synthesized derivatives, test animals were administered with 50–100 mg/kg of 3–6, respectively, by an oral route, and after 14 days, neither lethality nor a significative weight loss were observed. Finally, a structure–activity relationship (SAR) and a molecular docking analysis of 3–6 helped us to explain the trend observed in biological tests. Considering all these aspects, we propose the inhibition of MMP-8 and MMP-9 as a possible action mechanism of the synthesized derivatives.https://doi.org/10.3762/bjoc.16.108inflammationmolecular dockingorganophosphorus compounds
spellingShingle Abimelek Cortes-Pacheco
María Adelina Jiménez-Arellanes
Francisco José Palacios-Can
José Antonio Valcarcel-Gamiño
Rodrigo Said Razo-Hernández
María del Carmen Juárez-Vázquez
Adolfo López-Torres
Oscar Abelardo Ramírez-Marroquín
Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
Beilstein Journal of Organic Chemistry
inflammation
molecular docking
organophosphorus compounds
title Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
title_full Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
title_fullStr Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
title_full_unstemmed Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
title_short Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
title_sort synthesis antiinflammatory activity and molecular docking studies of bisphosphonic esters as potential mmp 8 and mmp 9 inhibitors
topic inflammation
molecular docking
organophosphorus compounds
url https://doi.org/10.3762/bjoc.16.108
work_keys_str_mv AT abimelekcortespacheco synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT mariaadelinajimenezarellanes synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT franciscojosepalacioscan synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT joseantoniovalcarcelgamino synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT rodrigosaidrazohernandez synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT mariadelcarmenjuarezvazquez synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT adolfolopeztorres synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors
AT oscarabelardoramirezmarroquin synthesisantiinflammatoryactivityandmoleculardockingstudiesofbisphosphonicestersaspotentialmmp8andmmp9inhibitors